MartyMPouillartPSchollSDrozJPAzabMBrionN. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med1990; 322: 816–21.
3.
FinleyRS. Nausea and vomiting. In: Koda-KimbleMAYoungLY, eds. Applied therapeutics: the clinical use of drugs. Vancouver, WA: Applied Therapeutics, 1992: 3.
4.
GrunbergSMHeskethPJ. Control of chemotherapy-induced emesis. N Engl J Med1993; 329: 1790–6.
5.
TriozziPLLaszloJ. Optimum management of nausea and vomiting in cancer chemotherapy. Drugs1987; 34: 136–49.
6.
GravesT. Emesis as a complication of cancer chemotherapy: pathophysiology, importance, and treatment. Pharmacotherapy1992; 12: 337–45.
7.
CubedduLX. Mechanisms by which cancer chemotherapeutic drugs induce emesis. Semin Oncol1992; 19 (6 suppl 15): 2–13.
8.
TortoricePVO'ConnellMB. Management of chemotherapy-induced nausea and vomiting. Pharmacotherapy1990; 10: 129–45.
9.
TyersMBFreemanAJ. Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists. Oncology1992; 49: 263–8.
10.
CubedduLXHoffmannISFuenmayorNFFinnAL. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med1990; 322: 810–6.
BorgeatAWilder-SmithOHGSuterPM. The nonhypnotic therapeutic applications of propofol. Anesthesiology1994; 80: 642–56.
13.
Product information. Diprivan (propofol). Wilmington, DE: Zeneca Pharmaceuticals, 1994.
14.
SebelPSLowdonJD. Propofol: a new intravenous anesthetic. Anesthesiology1989; 71: 260–77.
15.
BorgeatAWilder-SmithOHGSaiahMRifatK. Subhypnotic doses of propofol possess direct antiemetic properties. Anesth Analg1992; 74: 539–41.
16.
OstmanPLFaureEGlostenBKemenMRobertMKBedwellS. Is the antiemetic effect of the emulsion formulation of propofol due to the lipid emulsion?Anesth Analg1990; 71: 53640.
BorgeatAWilder-SmithOHGWilder-SmithCHForniMSuterPM. Adjuvant propofol for refractory cisplatin-associated nausea and vomiting. Lancet1992; 340: 679–80.
19.
BorgeatAWilder-SmithOForniMSuterPM. Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer. Can J Anaesth1994; 41: 1117–9.
20.
ScherCSAmarDMcDowallRHBarstSM. Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients. Can J Anaesth1992; 39: 170–2.
21.
HugCCMcLeskeyCHNahrwoldMLRoizenMFStanleyTHThistedRA. Hemodynamic effects of propofol: data from over 25,000 patients. Anesth Analg1993; 77 (suppl 4): S21–9.
22.
DiFlorioT. Is propofol a dopamine antagonist?Anesth Analg1993; 77: 197–201.
